Research Article

Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels

Volume: 5 Number: 1 March 17, 2025
EN TR

Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels

Abstract

The effectiveness of Doxorobucin (DOX), a commonly used anti-cancer and immunosuppressive medication, is hindered by its potential for organ toxicity. Prolonged use of DOX is associated with severe hepatocellular toxicity. This study reveals fresh insights into the therapeutic impact of esculetin (E) on DOX-induced kidney cell damage. Esculetin demonstrates its remedial effects by modulating heat shock protein signaling pathways. In our research, we explored the impact of DOX and E on the expression of the 70 kDa HSP gene family, including Hspa1a, Hspa4, and Hspa5, which are small stress proteins in Rattus norvegicus. The study involved the assignment of five different groups (Control, DOX, E50 mg/kg, E100 mg/kg, DOX+ E50 mg/kg, and DOX+ E100 mg/kg). Subsequently, kidney tissues were collected from rats, and cDNA libraries were generated at the conclusion of the application process. The Real-Time PCR method was employed using these libraries to detect HSP70 genes. Analyses conducted on Hspa1a, Hspa4 and Hspa5 expression revealed a statistically significant increase in the DOX group compared to the control group. Additionally, the combination of DOX and esculetin demonstrates a reduction in the increase caused by DOX alone. The study suggests that esculetin could serve as a potential protective agent for shielding kidney tissue from oxidative damage and apoptosis.

Keywords

Project Number

Ardahan Üniversitesi BAP birimi Proje No: 2021-003

Ethical Statement

Bu çalışma için etik komite onayı Atatürk Üniversitesi’nden (Protokol numarası: 2021/4–123) alınmıştır.

References

  1. Albakova, Z., Siam, M. K. S., Sacitharan, P. K., Ziganshin, R. H., Ryazantsev, D. Y., & Sapozhnikov, A. M. (2021). Extracellular heat shock proteins and cancer: New perspectives. Translational Oncology, 14(2). https://doi.org/10.1016/j.tranon.2020.100995
  2. Boopathy, L. R. A., Jacob-Tomas, S., Alecki, C., & Vera, M. (2022). Mechanisms tailoring the expression of heat shock proteins to proteostasis challenges. Journal of Biological Chemistry, 298(5). https://doi.org/10.1016/j.jbc.2022.101796.
  3. Boussada, M., Hammami, I., Ben Ali, R., Ammar, A. B., Alves, M., Oliveira, P. F., Akacha, A. B., Abdelkarim, I. L., Zekri, S., & El May, M. V. (2022). In vivo exposure to a new 2-cyano-2-p-nitrophenyl-N-benzylthioamide decreases doxorubicin-triggered structural damages in the mature testis. Andrologia, 54(11). https://doi.org/10.1111/and.14634.
  4. Ceylan, H., & Erdoğan, O. (2017). Cloning, expression, and characterization of human brain acetylcholinesterase in Escherichia coli using a SUMO fusion tag. Turkish Journal of Biology, 41(1), 77-87. https://doi.org/10.3906/biy-1602-83.
  5. De Freitas, G. B., Penteado, L., Miranda, M. M., Filassi, J. R., Baracat, E. C., & Linhares, I. M. (2022). The circulating 70 kDa heat shock protein (HSPA1A) level is a potential biomarker for breast carcinoma and its progression. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-17414-6
  6. Desai, V. G., Herman, E. H., Moland, C. L., Branham, W. S., Lewis, S. M., Davis, K. J., George, N. I., Lee, T., Kerr, S., & Fuscoe, J. C. (2013). Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model. Toxicology and Applied Pharmacology, 266(1), 109–121. https://doi.org/10.1016/j.taap.2012.10.025
  7. Dos Santos, N. S., Gonçalves, D. R., Balbinot, B., & Visioli, F. (2023). Is GRP78 (Glucose-regulated protein 78) a prognostic biomarker in differents types of cancer? A systematic review and meta-analysis. Pathology-Research and Practice, 242. https://doi.org/10.1016/j.prp.2023.154301.
  8. Dubrez, L., Causse, S., Borges Bonan, N., Dumétier, B., & Garrido, C. (2020). Heat-shock proteins: chaperoning DNA repair. Oncogene, 39(3), 516-529. https://doi.org/10.1038/s41388-019-1016-y.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Early Pub Date

October 4, 2024

Publication Date

March 17, 2025

Submission Date

January 29, 2024

Acceptance Date

September 20, 2024

Published in Issue

Year 2025 Volume: 5 Number: 1

APA
Yeşilkent, E. N., Kizir, D., Karağaç, M. S., Öztürk, N., Karadaş, H., Tosun, H., Karaman, M., Ceylan, H., & Demir, Y. (2025). Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels. Journal of Laboratory Animal Science and Practices, 5(1), 1-10. https://doi.org/10.62425/jlasp.1428071
AMA
1.Yeşilkent EN, Kizir D, Karağaç MS, et al. Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels. Journal of Laboratory Animal Science and Practices. 2025;5(1):1-10. doi:10.62425/jlasp.1428071
Chicago
Yeşilkent, Esra Nur, Duygu Kizir, Medine Sibel Karağaç, et al. 2025. “Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels”. Journal of Laboratory Animal Science and Practices 5 (1): 1-10. https://doi.org/10.62425/jlasp.1428071.
EndNote
Yeşilkent EN, Kizir D, Karağaç MS, Öztürk N, Karadaş H, Tosun H, Karaman M, Ceylan H, Demir Y (March 1, 2025) Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels. Journal of Laboratory Animal Science and Practices 5 1 1–10.
IEEE
[1]E. N. Yeşilkent et al., “Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels”, Journal of Laboratory Animal Science and Practices, vol. 5, no. 1, pp. 1–10, Mar. 2025, doi: 10.62425/jlasp.1428071.
ISNAD
Yeşilkent, Esra Nur - Kizir, Duygu - Karağaç, Medine Sibel - Öztürk, Neslihan - Karadaş, Habibe - Tosun, Hilal - Karaman, Melike - Ceylan, Hamid - Demir, Yeliz. “Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels”. Journal of Laboratory Animal Science and Practices 5/1 (March 1, 2025): 1-10. https://doi.org/10.62425/jlasp.1428071.
JAMA
1.Yeşilkent EN, Kizir D, Karağaç MS, Öztürk N, Karadaş H, Tosun H, Karaman M, Ceylan H, Demir Y. Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels. Journal of Laboratory Animal Science and Practices. 2025;5:1–10.
MLA
Yeşilkent, Esra Nur, et al. “Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels”. Journal of Laboratory Animal Science and Practices, vol. 5, no. 1, Mar. 2025, pp. 1-10, doi:10.62425/jlasp.1428071.
Vancouver
1.Esra Nur Yeşilkent, Duygu Kizir, Medine Sibel Karağaç, Neslihan Öztürk, Habibe Karadaş, Hilal Tosun, Melike Karaman, Hamid Ceylan, Yeliz Demir. Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels. Journal of Laboratory Animal Science and Practices. 2025 Mar. 1;5(1):1-10. doi:10.62425/jlasp.1428071

Cited By

Content of this journal is licensed under a Creative Commons Attribution NonCommercial 4.0 International License

29929